A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Stopped Study halted prematurely by sponsor and will not resume, participants are no longer being examined or receiving intervention.

Conditions

• Respiratory Tract Infection

Interventions

• BIOLOGICAL: Formulation A
• BIOLOGICAL: Formulation B
• BIOLOGICAL: Formulation C
• BIOLOGICAL: Placebo

Sponsor

Pfizer